143 related articles for article (PubMed ID: 9624296)
1. Secretory leukoprotease inhibitor: a native antimicrobial protein presenting a new therapeutic option?
Tomee JF; Koëter GH; Hiemstra PS; Kauffman HF
Thorax; 1998 Feb; 53(2):114-6. PubMed ID: 9624296
[TBL] [Abstract][Full Text] [Related]
2. Human immunodeficiency virus type-1 (HIV-1) replication is unaffected by human secretory leukocyte protease inhibitor.
Turpin JA; Schaeffer CA; Bu M; Graham L; Buckheit RW; Clanton D; Rice WG
Antiviral Res; 1996 Mar; 29(2-3):269-77. PubMed ID: 8739605
[TBL] [Abstract][Full Text] [Related]
3. Secretory leukocyte protease inhibitor (SLPI): oxidation of SLPI does not explain its variable anti-HIV activity.
Konopka K; Shine N; Pretzer E; Düzgüneş N
J Dent Res; 1999 Dec; 78(12):1773-6. PubMed ID: 10598905
[TBL] [Abstract][Full Text] [Related]
4. Effect of menstrual status on antibacterial activity and secretory leukocyte protease inhibitor production by human uterine epithelial cells in culture.
Fahey JV; Wira CR
J Infect Dis; 2002 Jun; 185(11):1606-13. PubMed ID: 12023766
[TBL] [Abstract][Full Text] [Related]
5. Antileukoprotease: an endogenous protein in the innate mucosal defense against fungi.
Tomee JF; Hiemstra PS; Heinzel-Wieland R; Kauffman HF
J Infect Dis; 1997 Sep; 176(3):740-7. PubMed ID: 9291323
[TBL] [Abstract][Full Text] [Related]
6. Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro.
McNeely TB; Dealy M; Dripps DJ; Orenstein JM; Eisenberg SP; Wahl SM
J Clin Invest; 1995 Jul; 96(1):456-64. PubMed ID: 7615818
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory function of secretory leukocyte proteinase inhibitor (SLPI) in human saliva is HIV-1 specific and varies with virus tropism.
Skott P; Lucht E; Ehnlund M; Björling E
Oral Dis; 2002 May; 8(3):160-7. PubMed ID: 12108760
[TBL] [Abstract][Full Text] [Related]
8. Glycosaminoglycans regulate elastase inhibition by oxidized secretory leukoprotease inhibitor.
Ying QL; Kemme M; Saunders D; Simon SR
Am J Physiol; 1997 Mar; 272(3 Pt 1):L533-41. PubMed ID: 9124611
[TBL] [Abstract][Full Text] [Related]
9. Efficient production of the C-terminal domain of secretory leukoprotease inhibitor as a thrombin-cleavable fusion protein in Escherichia coli.
Masuda K; Kamimura T; Kanesaki M; Ishii K; Imaizumi A; Sugiyama T; Suzuki Y; Ohtsuka E
Protein Eng; 1996 Jan; 9(1):101-6. PubMed ID: 9053897
[TBL] [Abstract][Full Text] [Related]
10. Secretory leukocyte protease inhibitor (SLPI) in mucosal fluids inhibits HIV-I.
Wahl SM; McNeely TB; Janoff EN; Shugars D; Worley P; Tucker C; Orenstein JM
Oral Dis; 1997 May; 3 Suppl 1():S64-9. PubMed ID: 9456660
[TBL] [Abstract][Full Text] [Related]
11. Secretory leukocyte protease inhibitor prevents allergen-induced pulmonary responses in animal models of asthma.
Wright CD; Havill AM; Middleton SC; Kashem MA; Lee PA; Dripps DJ; O'Riordan TG; Bevilacqua MP; Abraham WM
J Pharmacol Exp Ther; 1999 May; 289(2):1007-14. PubMed ID: 10215681
[TBL] [Abstract][Full Text] [Related]
12. Secretory leukoprotease inhibitor attenuates lung injury induced by continuous air embolization into sheep.
Gossage JR; Perkett EA; Davidson JM; Starcher BC; Carmichael D; Brigham KL; Meyrick B
J Appl Physiol (1985); 1995 Oct; 79(4):1163-72. PubMed ID: 8567558
[TBL] [Abstract][Full Text] [Related]
13. [Effects of secretory leukocyte protease inhibitor on the production of some cytokines and nitric oxide by murine peritoneal macrophages in response to lipopolysaccharide stimulation and M. avium complex infection].
Sano C; Shimizu T; Sato K; Ogasawara K; Tomioka H
Kekkaku; 1999 Jul; 74(7):563-70. PubMed ID: 10481411
[TBL] [Abstract][Full Text] [Related]
14. Interaction of secretory leukocyte protease inhibitor with proteinase-3.
Rao NV; Marshall BC; Gray BH; Hoidal JR
Am J Respir Cell Mol Biol; 1993 Jun; 8(6):612-6. PubMed ID: 8100709
[TBL] [Abstract][Full Text] [Related]
15. IgE-mediated histamine release from nasal mucosa is inhibited by SLPI (secretory leukocyte protease inhibitor) to the level of spontaneous release.
Westin U; Lundberg E; Ohlsson K
Mediators Inflamm; 1998; 7(3):217-20. PubMed ID: 9705610
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of murine neutrophil serine proteinases by human and murine secretory leukocyte protease inhibitor.
Wright CD; Kennedy JA; Zitnik RJ; Kashem MA
Biochem Biophys Res Commun; 1999 Jan; 254(3):614-7. PubMed ID: 9920787
[TBL] [Abstract][Full Text] [Related]
17. Secretory leukocyte protease inhibitor suppresses the production of monocyte prostaglandin H synthase-2, prostaglandin E2, and matrix metalloproteinases.
Zhang Y; DeWitt DL; McNeely TB; Wahl SM; Wahl LM
J Clin Invest; 1997 Mar; 99(5):894-900. PubMed ID: 9062347
[TBL] [Abstract][Full Text] [Related]
18. Suppression of macrophage responses to bacterial lipopolysaccharide by a non-secretory form of secretory leukocyte protease inhibitor.
Zhu J; Nathan C; Ding A
Biochim Biophys Acta; 1999 Sep; 1451(2-3):219-23. PubMed ID: 10556576
[TBL] [Abstract][Full Text] [Related]
19. Secretory leukocyte protease inhibitor: inhibition of human immunodeficiency virus-1 infection of monocytic THP-1 cells by a newly cloned protein.
Shine NR; Wang SC; Konopka K; Burks EA; Düzgüneş N; Whitman CP
Bioorg Chem; 2002 Aug; 30(4):249-63. PubMed ID: 12392704
[TBL] [Abstract][Full Text] [Related]
20. Secretory leukocyte protease inhibitor blocks infectivity of primary monocytes and mononuclear cells with both monocytotropic and lymphocytotropic strains of human immunodeficiency virus type I.
Shugars DC; Sauls DL; Weinberg JB
Oral Dis; 1997 May; 3 Suppl 1():S70-2. PubMed ID: 9456661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
